Susquehanna International Group’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.2M | Buy |
1,021,604
+987,349
| +2,882% | +$15.6M | ﹤0.01% | 3239 |
|
|
2025
Q4 | $625K | Sell |
34,255
-339,538
| -91% | -$5.72M | ﹤0.01% | 8289 |
|
|
2025
Q3 | $5.48M | Sell |
373,793
-110,924
| -23% | -$1.9M | ﹤0.01% | 3931 |
|
|
2025
Q2 | $8.83M | Buy |
484,717
+176,526
| +57% | +$3.6M | ﹤0.01% | 3007 |
|
|
2025
Q1 | $6.11M | Buy |
308,191
+145,937
| +90% | +$2.52M | ﹤0.01% | 3282 |
|
|
2024
Q4 | $2.78M | Buy |
162,254
+100,566
| +163% | +$1.89M | ﹤0.01% | 4612 |
|
|
2024
Q3 | $1.23M | Sell |
61,688
-15,951
| -21% | -$248K | ﹤0.01% | 6331 |
|
|
2024
Q2 | $868K | Sell |
77,639
-88,816
| -53% | -$745K | ﹤0.01% | 6917 |
|
|
2024
Q1 | $1.1M | Sell |
166,455
-69,778
| -30% | -$381K | ﹤0.01% | 6662 |
|
|
2023
Q4 | $1.07M | Sell |
236,233
-135,489
| -36% | -$501K | ﹤0.01% | 6835 |
|
|
2023
Q3 | $1.33M | Buy |
371,722
+245,602
| +195% | +$945K | ﹤0.01% | 5989 |
|
|
2023
Q2 | $465K | Sell |
126,120
-296,412
| -70% | -$1.1M | ﹤0.01% | 8490 |
|
|
2023
Q1 | $1.4M | Buy |
422,532
+18,708
| +5% | +$64.7K | ﹤0.01% | 5962 |
|
|
2022
Q4 | $1.57M | Sell |
403,824
-47,039
| -10% | -$145K | ﹤0.01% | 5187 |
|
|
2022
Q3 | $1.09M | Buy |
450,863
+5,633
| +1% | +$13.5K | ﹤0.01% | 6408 |
|
|
2022
Q2 | $882K | Sell |
445,230
-539,793
| -55% | -$1.06M | ﹤0.01% | 6833 |
|
|
2022
Q1 | $1.8M | Sell |
985,023
-374,508
| -28% | -$584K | ﹤0.01% | 5707 |
|
|
2021
Q4 | $1.92M | Buy |
1,359,531
+158,088
| +13% | +$208K | ﹤0.01% | 5611 |
|
|
2021
Q3 | $1.36M | Buy |
1,201,443
+553,754
| +85% | +$776K | ﹤0.01% | 6748 |
|
|
2021
Q2 | $1.04M | Sell |
647,689
-42,365
| -6% | -$74.5K | ﹤0.01% | 7666 |
|
|
2021
Q1 | $1.21M | Buy |
690,054
+297,899
| +76% | +$682K | ﹤0.01% | 7209 |
|
|
2020
Q4 | $765K | Buy |
392,155
+264,905
| +208% | +$557K | ﹤0.01% | 7317 |
|
|
2020
Q3 | $304K | Sell |
127,250
-63,939
| -33% | -$175K | ﹤0.01% | 8674 |
|
|
2020
Q2 | $560K | Buy |
191,189
+16,824
| +10% | +$48.3K | ﹤0.01% | 7133 |
|
|
2020
Q1 | $502K | Buy |
174,365
+79,966
| +85% | +$276K | ﹤0.01% | 6925 |
|
|
2019
Q4 | $378K | Sell |
94,399
-71,378
| -43% | -$311K | ﹤0.01% | 7541 |
|
|
2019
Q3 | $738K | Buy |
165,777
+30,695
| +23% | +$128K | ﹤0.01% | 6385 |
|
|
2019
Q2 | $523K | Buy |
135,082
+117,046
| +649% | +$517K | ﹤0.01% | 7166 |
|
|
2019
Q1 | $68K | Buy |
+18,036
| New | +$63.8K | ﹤0.01% | 8393 |
|
|
2018
Q2 | – | Sell |
-94,476
| Closed | -$435K | – | 9514 |
|
|
2018
Q1 | $435K | Buy |
+94,476
| New | +$376K | ﹤0.01% | 6914 |
|
|
2015
Q2 | – | Sell |
-30,000
| Closed | -$294K | – | 10057 |
|
|
2015
Q1 | $294K | Buy |
+30,000
| New | +$302K | ﹤0.01% | 8013 |
|
Other funds holding ADMA
VCM
VPM
N